HIGHLIGHTS
- who: Sandeep Kumar Parvathareddy from the Shahid Beheshti University of Medical Sciences, Iran have published the paper: X-linked inhibitor of apoptosis protein (XIAP) predicts disease-free survival in BRAFV600E mutant papillary thyroid carcinoma in middle eastern patients, in the Journal: (JOURNAL)
- what: The aim of this study was to investigate whether BRAFV600E mutational status is associated with XIAP alteration and whether these associations can synergistically improve the ability to predict prognosis in a large cohort of Middle Eastern PTC patients. The authors investigated whether BRAFV600E mutation may better predict PTC recurrence in the presence . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.